27-29 April, 2022

1st International Advanced Course of

Diabetic Neuropathic Foot

and its Consequences

#CODINEF22

 

Diabetic Neuropathic Foot and its Consequences is the 1st international advanced course that aims to combine education, training and specialization of health care specialists on diagnostics and treatment of diabetic foot neuropathy. 

Course Director: Prof. Dr. Ariel Odriozola. Barcelona, ​​Spain.

Diabetic peripheral neuropathy (DPN) is a debilitating condition affecting as many as one-half of all patients with diabetes during the course of their disease (1). The progressive, irreversible course of the disease ultimately leads to an increased incidence of ulceration and limb amputations (2).
Diabetes Care 2004 May; 27(5): 1153-1159
The European Association For The Study Of Diabetes - NEURODIAB, the Asociación Latinoamericana De La Diabetes – ALAD, the Instituto Nacional De Diabetes Y Endocriniología – INDEN and NEURODIAB - Society for Diabetic Neuropathy invites you to the 1st edition of the international course on Diabetic Neuropathic Foot and its Consequences, which will take place online on the 27th - 28th – 29th of April, 2022, Between the hours 17:00-20:00 (Central European Time)
During the event, the participants will have the opportunity to interact and exchange experiences and good practices with internationally renowned experts in diabetes and diabetic neuropathy.
The participants will have the opportunity to ask questions in real time. All the participants are encouraged to be active. The event follows a high-quality scientific program. It includes scientific sessions followed by Q&A sessions, as well as case presentations dedicated to various diabetic pathologies.
Topics will include:
We are convinced that everyone's participation in this event will make a significant contribution to their professional development and will help them build a good personal and professional brand.
The event will be LIVE broadcast and can only be watched by those who registered (they will receive a username and password one day before the event). In addition, the recording of the event will be available on the platform for 30 days.

The scientific committee and the organizers of this event, express their heartfelt and recognized gratitude for the effort made by each of the participating Professionals and the institutions for their support so that this 1st course can be carried out for the benefit of all those patients who suffer from Diabetes Mellitus and the professionals who assist them.

We look forward to seeing you!

The organization has been carried out by:

  • Director of the course, Prof. Dr. Ariel Odriozola.
  • Biomedical engineer Samantha Odriozola.
  • Biochimist Ph.D Norina Gavan.

REGISTER HERE

Registrations are open until the start of the event: 27th of April 2022, 15:00 PM 

 

COURSE SCHEDULE

The presentations are held by international speakers with expertise in diabetes, diabetic neuropathy and diabetic foot.

Courses will start at 17:00 (Central European Time)

Lectures already confirmed: 

 

Download from HERE the Course Schedule of CODINEF22 

the 1st INTERNATIONAL ADVANCED COURSE ON DIABETIC NEUROPATHIC FOOT AND ITS CONSEQUENCES

The courses are held online, on a special platform, on which only people with confirmed registration can attend.

Your personal login info will be sent by e-mail a few days before the event.

 

Stay tooned, for the final schedule.

Ariel Odriozola Orlandi

Ariel Odriozola Orlandi

Abd Tahrani

Abd Tahrani

Ammar Ibrahim

Ammar Ibrahim

Ana Begoña Arribas Díaz

Ana Begoña Arribas Díaz

Anand Pillai

Anand Pillai

Carles Vergés Salas

Carles Vergés Salas

Didac Mauricio

Didac Mauricio

Douglas Villarroel

Douglas Villarroel

Elena Planell

Elena Planell

Fermin Martinez De Jesus

Fermin Martinez De Jesus

Francisco Salvador Sagüe

Francisco Salvador Sagüe

Gabriela Radulian

Gabriela Radulian

Georgios Ponirakis

Georgios Ponirakis

Giacomo Clerici

Giacomo Clerici

Graciela Fuente

Graciela Fuente

Helena Schmid

Helena Schmid

Hermelinda Pedrosa

Hermelinda Pedrosa

Isabel Sacco

Isabel Sacco

Iulia Rusu

Iulia Rusu

José Daniel Braver

José Daniel Braver

José Luis Lázaro Martínez

José Luis Lázaro Martínez

María Jesús Jiménez Mazuelas

María Jesús Jiménez Mazuelas

Mihai Ionac

Mihai Ionac

Nikolaos Papanas

Nikolaos Papanas

Niels Ejskjaer

Niels Ejskjaer

Norina Gâvan

Norina Gâvan

Paul Valensi

Paul Valensi

Paulina Cisneros Clavijo

Paulina Cisneros Clavijo

Prashanth Vas

Prashanth Vas

Rayaz Malik

Rayaz Malik

Robert G. Frykberg

Robert G. Frykberg

Rodica Pop-Busui

Rodica Pop-Busui

Sergio Mazuelas Álvarez

Sergio Mazuelas Álvarez

Shailesh Chhotala

Shailesh Chhotala

Vincenza Spallone

Vincenza Spallone

This course is open for everyone involved in the treatment of diabetic foot, with a special focus on healthcare specialists like: Resident and young doctors, specializing in diabetes, neurology, general surgery, vascular surgery, orthopedics, internal medicine, endocrinology, cardiology and family medicine and other healthcare professionals like nurses, physiotherapists and podiatrists, as members of the multidisciplinary team.

The number of participants is limited to 150.

The purpose of the advanced course is to educate, train and specialize exclusively physicians and podiatrists on diabetic foot neuropathy, diagnosis and treatment.

In an era, where personalized treatment is requested, reliable and contrasted technologies for early quantified diagnoses, as well as prescribing the right treatment, such a course is essential for healthcare professionals. Physicians and Podiatrists need to be empowered on their daily activity with a quick and reliable diagnoses as well as to prescribe the correct treatment for the specific diabetic foot neuropathy.

As the 4th Revolution we are living on, technology has its place to support the diagnoses patient’s tendency through its data collection and the specific treatments for the diabetic foot neuropathy of our patients.

The diagnostic precision of diabetic neuropathy leads / leads to a correct decision of the treatment, thus being able to reduce the injuries and the number of amputations, the most important being the improvement of the quality of life of patients with diabetes.